FOXP3 and neoplasm: The data confirm that high levels of FoxP3+ Tregs within the tumor microenvironment are significantly correlated with a lack of response to immunotherapy, consistent with the well-known immunosuppressive function of Tregs that can inhibit the antitumor immune response.